2,3-diphosphoglycerate has been researched along with Diabetic Neuropathies in 7 studies
2,3-Diphosphoglycerate: A highly anionic organic phosphate which is present in human red blood cells at about the same molar ratio as hemoglobin. It binds to deoxyhemoglobin but not the oxygenated form, therefore diminishing the oxygen affinity of hemoglobin. This is essential in enabling hemoglobin to unload oxygen in tissue capillaries. It is also an intermediate in the conversion of 3-phosphoglycerate to 2-phosphoglycerate by phosphoglycerate mutase (EC 5.4.2.1). (From Stryer Biochemistry, 4th ed, p160; Enzyme Nomenclature, 1992, p508)
2,3-bisphosphoglyceric acid : A bisphosphoglyceric acid that is glyceric acid carrying two phospho substituents at positions 2 and 3.
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosseini, A | 1 |
| Sharifzadeh, M | 1 |
| Rezayat, SM | 1 |
| Hassanzadeh, G | 1 |
| Hassani, S | 1 |
| Baeeri, M | 1 |
| Shetab-Bushehri, V | 1 |
| Kuznetsov, DA | 1 |
| Abdollahi, M | 1 |
| Pańkowska, E | 1 |
| Szypowska, A | 1 |
| Wysocka, M | 1 |
| Lipka, M | 1 |
| Nakamura, J | 3 |
| Koh, N | 3 |
| Sakakibara, F | 3 |
| Hamada, Y | 3 |
| Wakao, T | 2 |
| Hara, T | 3 |
| Mori, K | 3 |
| Nakashima, E | 2 |
| Naruse, K | 3 |
| Hotta, N | 3 |
| Fukasawa, H | 1 |
| Kakuta, H | 1 |
| Sakamoto, N | 1 |
| Kamijo, M | 1 |
| Farber, SD | 1 |
| Farber, MO | 1 |
| Brewer, G | 1 |
| Magnes, CJ | 1 |
| Peterson, RG | 1 |
| Zhou, ZG | 1 |
7 other studies available for 2,3-diphosphoglycerate and Diabetic Neuropathies
| Article | Year |
|---|---|
Benefit of magnesium-25 carrying porphyrin-fullerene nanoparticles in experimental diabetic neuropathy.
Topics: 2,3-Diphosphoglycerate; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Diabetic Neuropathie | 2010 |
[The role of 2,3-DPG in nerve conduction of children with type 1 diabetes].
Topics: 2,3-Diphosphoglycerate; Adolescent; Child; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; | 2005 |
Polyol pathway, 2,3-diphosphoglycerate in erythrocytes and diabetic neuropathy in rats.
Topics: 2,3-Diphosphoglycerate; Aldehyde Reductase; Animals; Body Weight; Diabetic Neuropathies; Diphosphogl | 1995 |
Nerve function and blood flow in Otsuka Long-Evans Tokushima Fatty rats with sucrose feeding: effect of an anticoagulant.
Topics: 2,3-Diphosphoglycerate; Alcohols; Animals; Anticoagulants; Blood Glucose; Body Weight; Carbohydrate | 1996 |
Physiological and morphometric analyses of neuropathy in sucrose-fed OLETF rats.
Topics: 2,3-Diphosphoglycerate; Aldehyde Reductase; Animals; Diabetes Mellitus, Type 2; Diabetic Neuropathie | 2001 |
Oxygen affinity of hemoglobin and peripheral nerve degeneration in experimental diabetes.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Animals; Diabetes Mellitus, Experimental; Diabetic A | 1991 |
[Relation between 2,3-DPG changes and venous blood gas in diabetic patients with peripheral neuropathy].
Topics: 2,3-Diphosphoglycerate; Adolescent; Adult; Blood Gas Analysis; Diabetic Neuropathies; Diphosphoglyce | 1987 |